It’s no secret that January was a nightmare for many tech and healthcare funds, especially for the many funds that were down by double digits. These include big names like Tiger Global, Melvin Capital, Perceptive Advisors, and RTW Investments.
But several funds that specialize in tech and life sciences stocks did manage to make money last month.
Averill
